NBY

Novabay Pharmaceuticals

$1.22

-0.14 (-10.29%)

Analyst Overview

Target Price:

Date: 07.10.2025

$0.85

(-30.33%)

Strong Buy: 0

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Description:

NovaBay Pharmaceuticals Inc. is a cutting-edge medical device company specializing in the development of innovative eye care products, catering to both domestic and international markets. Based in Emeryville, California, NovaBay leverages its proprietary technology to address unmet needs in ocular health, focusing on conditions such as eye infections and inflammation. The company's commitment to improving patient outcomes through advanced therapeutic solutions positions it strategically within the growing eye care sector.

Exchange:

NYSE MKT

Country:

USA

Sector:

HEALTHCARE

Industry:

BIOTECHNOLOGY

Address:

2000 POWELL STREET, EMERYVILLE, CA, UNITED STATES, 94608

Fiscal year end:

December

Market capitalization:

$8.17 Million

EBITDA:

-$5.63 Million

PERatio:

0.591

EPS:

2.3

Dividend per share:

$0.00

Dividend yield:

0.0%

Beta:

0.54

Dividends for 10 years

Income Statements for 10 years

Earnings calender

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:

$1,000

How much will you earn in 10 years:

-100%

How much will you get:

Prices dates:

30-09-2015: $5,467.27 and 30-09-2025: $1.28